TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,866 Cr | ₹1,844 Cr | ₹1,944 Cr | ₹1,632 Cr | ₹1,523 Cr |
What is the latest Sundry Debtors ratio of TORRENT PHARMACEUTICALS ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹1,866 Cr |
Mar2024 | ₹1,844 Cr |
Mar2023 | ₹1,944 Cr |
Mar2022 | ₹1,632 Cr |
Mar2021 | ₹1,523 Cr |
How is Sundry Debtors of TORRENT PHARMACEUTICALS Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹1,866 Cr | 1.20 | |
Mar2024 | ₹1,844 Cr | -5.12 | |
Mar2023 | ₹1,944 Cr | 19.07 | |
Mar2022 | ₹1,632 Cr | 7.16 | |
Mar2021 | ₹1,523 Cr | - |
Compare Sundry Debtors of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹121,150.6 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,197.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,634.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹126,082.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,783.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics | |
MANKIND PHARMA | ₹107,183.0 Cr | 1.8% | 6.6% | 8.2% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | NA |
-0.9% |
4.9% |
SENSEX | 1% |
2.1% |
0.5% |
You may also like the below Video Courses